Skip to main content

AusPAR: BNT162b2 (mRNA)

Australian Public Assessment Report
Device/Product Name
Comirnaty
Active ingredients
BNT162b2 (mRNA)
AusPAR Date
Published
Submission Number
PM-2021-04582-1-2
Submission Type
Major variation (change of dose regimen)
Decision
Approved for provisional registration

Help us improve the Therapeutic Goods Administration site